K3-Innovations, Inc. is a clinical research services provider for the bio/pharmaceutical and medical device industries. Founded in 2013, the company's skilled teams are experienced in global clinical trials of all phases and diverse therapeutic areas. Their services include biostatistics and programming, SDTM implementation, functional service provider, consulting, and staffing services. K3-Innovations prioritizes integrity and compliance, ensuring their services are governed by well-defined SOPs and policies, compliant with regulatory requirements such as ICH/GCP and FDA 21 CFR Part 11. Their mission revolves around client satisfaction and finding efficient, cost-effective solutions, acting in the best interests of clients, employees, and communities. The company's commitment to delivering high-quality, cost-effective, and timely solutions aligns with the growing demands of the Health Care, Medical Devices, and Pharmaceutical industries. With a focus on client satisfaction and regulatory compliance, K3-Innovations presents a promising opportunity for venture capital investment in the rapidly evolving clinical research sector.
There is no investment information
No recent news or press coverage available for K3-Innovations, Inc..